Translating AI-Enabled Multi-Omics Diagnostics into Clinical Practice: Regulatory, Reimbursement, and Adoption Pathways

Translating AI-Enabled Multi-Omics Diagnostics into Clinical Practice: Regulatory, Reimbursement, and Adoption Pathways

Date & Time 25 February 2026,2:30 pm – 3:10 pm (UK time)/ 9.30am - 10.10am EST
Duration: 40 minutes

Discussion Focus

This session will explore how AI-enabled multi-omics diagnostics can be effectively translated into clinical practice, with emphasis on:

• Regulatory pathways
• Reimbursement considerations
• Clinical adoption challenges and enablers

Confirmed Facilitators:

Junmei Cairns, Associate Director & Precision Medicine Lead, AZ

Joe Lennerz, Chair, PIcc Alliance

To attend this interest group session you need to be a Premium LifeScienceXchange member.

Secure all the benefits and sign-up for Premium membership now

*If you’re already a Premium member your exclusive invite will be sent direct to your inbox